© 1995 American Heart Association, Inc.
Articles |
Role of Calcium-Activated Neutral Protease (Calpain) in Cell Death in Cultured Neonatal Rat Cardiomyocytes During Metabolic Inhibition
Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.
From the Department of Cardiology, University Hospital, Leiden, Netherlands.
Correspondence to D.E. Atsma, MD, Department of Cardiology, C5-P, University Hospital, PO Box 9600, 2300 RC Leiden, Netherlands.
Abstract Calcium-activated neutral protease (CANP), also known as calpain, has been implicated in the development of cell death in ischemic hearts. CANP is thought to be activated by the calcium overload that develops during ischemia. We studied the involvement of CANP in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition (5 mmol/L NaCN+10 mmol/L 2-deoxyglucose). First, we isolated CANP using ion exchange and affinity chromatography. Then the efficacy of the CANP inhibitors calpain I inhibitor, leupeptin, and E64 to inhibit isolated CANP activity was tested with the use of fluorescently labeled ß-casein as a substrate. The IC50 for the inhibitors was between 2.1 and 56 µmol/L. Uptake of the inhibitors by intact cells was assessed with the use of 99mTc-radiolabeled inhibitors. The calculated intracellular inhibitor concentrations were sufficiently high to yield substantial inhibition of intracellular CANP activity. Intracellular CANP activity was measured directly with the use of the cell-permeant fluorogenic CANP-specific substrate N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methyl-coumarin. During metabolic inhibition, intracellular CANP activity was increased compared with control incubation. The time course of CANP activation was compatible with that of the rise in [Ca2+]i, as measured by fura 2 and digital imaging fluorescence microscopy. Calpain I inhibitor and leupeptin inhibited intracellular CANP activity both during metabolic inhibition and control incubation, whereas E64 did not. Despite their substantial inhibition of intracellular CANP activity, calpain I inhibitor and leupeptin did not attenuate cell death during metabolic inhibition. We therefore conclude that intracellular CANP in cardiomyocytes is activated during metabolic inhibition, but it does not play a major role in the development of cell death.
Key Words: myocytes • cell death • metabolic inhibition • calcium-activated neutral protease • protease inhibitors
This article has been cited by other articles:
 |
|
 |
|
  D. D. Arrington and R. G. Schnellmann Targeting of the molecular chaperone oxygen-regulated protein 150 (ORP150) to mitochondria and its induction by cellular stress Am J Physiol Cell Physiol, February 1, 2008; 294(2): C641 - C650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Arrington, T. R. Van Vleet, and R. G. Schnellmann Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1159 - C1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nagy, V. Champattanachai, R. B. Marchase, and J. C. Chatham Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine Am J Physiol Cell Physiol, January 1, 2006; 290(1): C57 - C65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. van der Laarse Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res, October 1, 2002; 56(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns Molecular mechanisms of remodeling in human atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 315 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J.J.M Brundel, J. Ausma, I. C van Gelder, J. J.L Van Der Want, W. H van Gilst, H. J.G.M Crijns, and R. H Henning Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 380 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Cuzzocrea, M C McDonald, E Mazzon, H Mota-Filipe, T Centorrino, M L Terranova, A Ciccolo, D Britti, A P Caputi, and C Thiemermann Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat Gut, April 1, 2001; 48(4): 478 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, A. A. M. Wilde, W. H. Van Gilst, and H. J. G. M. Crijns Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels J. Am. Coll. Cardiol., March 1, 2001; 37(3): 926 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. McDONALD, H. MOTA-FILIPE, A. PAUL, S. CUZZOCREA, M. ABDELRAHMAN, S. HARWOOD, R. PLEVIN, P. K. CHATTERJEE, M. M. YAQOOB, and C. THIEMERMANN Calpain inhibitor I reduces the activation of nuclear factor-{kappa}B and organ injury/dysfunction in hemorrhagic shock FASEB J, January 1, 2001; 15(1): 171 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cuzzocrea, M. C. McDonald, E. Mazzon, D. Siriwardena, I. Serraino, L. Dugo, D. Britti, G. Mazzullo, A. P. Caputi, and C. Thiemermann Calpain Inhibitor I Reduces the Development of Acute and Chronic Inflammation Am. J. Pathol., December 1, 2000; 157(6): 2065 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Sobel and M. M. LeWinter Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1355 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nethery, D. Stofan, L. Callahan, A. DiMarco, and G. Supinski Formation of reactive oxygen species by the contracting diaphragm is PLA2 dependent J Appl Physiol, August 1, 1999; 87(2): 792 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. McDonough, D. K. Arrell, and J. E. Van Eyk Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury Circ. Res., January 22, 1999; 84(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Kondo, C. S. Apstein, F. R. Eberli, D. L. Tillotson, and T. M. Suter Increased calcium loading and inotropy without greater cell death in hypoxic rat cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2272 - H2282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-H. Ning, C.-S. Xu, Y. C. Song, Y. Xiao, Y.-J. Hu, F. M. Lupinetti, and M. A. Portman Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H786 - H793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Van Eyk, F. Powers, W. Law, C. Larue, R. S. Hodges, and R. J. Solaro Breakdown and Release of Myofilament Proteins During Ischemia and Ischemia/Reperfusion in Rat Hearts : Identification of Degradation Products and Effects on the pCa-Force Relation Circ. Res., February 9, 1998; 82(2): 261 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nawada, T. Murakami, T. Iwase, K. Nagai, Y. Morita, I. Kouchi, M. Akao, and S. Sasayama Inhibition of Sarcolemmal Na+,K+-ATPase Activity Reduces the Infarct Size–Limiting Effect of Preconditioning in Rabbit Hearts Circulation, July 15, 1997; 96(2): 599 - 604. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. M. Vanags, M. I. Porn-Ares, S. Coppola, D. H. Burgess, and S. Orrenius Protease Involvement in Fodrin Cleavage and Phosphatidylserine Exposure in Apoptosis J. Biol. Chem., December 6, 1996; 271(49): 31075 - 31085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Matsumura, E. Saeki, M. Inoue, M. Hori, T. Kamada, and H. Kusuoka Inhomogeneous Disappearance of Myofilament-Related Cytoskeletal Proteins in Stunned Myocardium of Guinea Pig Circ. Res., September 1, 1996; 79(3): 447 - 454. [Abstract] [Full Text]
|
|